Adamis pharmaceuticals to fund zimhi® clinical study with university of leiden opioid expert

San diego, july 28, 2023 (globe newswire) -- adamis pharmaceuticals corporation (nasdaq: admp), a commercial-stage biopharmaceutical company, today announced the company has committed to fund an unrestricted research grant to the leiden university medical center (lumc) anesthesia and pain research unit. the funding will support the work of albert dahan, md, phd, a world expert on opioid-induced respiratory depression (opioid overdose) and professor of anesthesiology at the university. dr. dahan has been working with the fda since 2020 to understand better methods of reversing fentanyl overdoses.
ADMP Ratings Summary
ADMP Quant Ranking